MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2017 International Congress

    Expression of late cell cycle markers in Parkinson Disease and Lewy Body Dementia

    I. Martinez-Valbuena, R. Valenti-Azcarate, M.M. Carmona-Abellan, I. Marcilla-Garcia, I. Gaston-Zubimendi, G. Marti-Andres, M.-T. Tuñon-Alvarez, M.-R. Luquin-Piudo (Pamplona, Spain)

    Objective: The objective of this study is to determine the expression of late cell cycle markers in Parkinson Disease (PD) and Lewy Body Dementia (LBD) Background:…
  • 2017 International Congress

    Premovement betaband event-related desynchronization related to simple lower limb movement and simulated gait initiation in Parkinson’s disease patients: MEG study

    J.Y. Yun, J.S. Kim, H.W. Lee (Seoul, Republic of Korea)

    Objective: To compare premovement event related desynchronization (ERD) between simple lower limb movement and simulated gait initiation in Parkinson’s disease (PD) patients using Magnetoencephalography (MEG).…
  • 2017 International Congress

    Antibody binding differences in alpha-synuclein from Parkinson’s disease and multiple system atrophy

    T. Yamasaki, A. Welleford (Lexington, KY, USA)

    Objective: Determine whether alpha-synuclein derived from Parkinson's disease (PD) and multiple system atrophy (MSA) brains has different conformations as defined by biochemical and antibody-based approaches. Background: There…
  • 2017 International Congress

    Development of nano-formulation containing crocetin for the protective and beneficial effect against 6-hydroxydopamine induced Parkinson’s disease model via altered the genetic backgrounds

    V. Kumar, A. Verma, P. Bhatt (Allahabad, India)

    Objective: Parkinson’s disease (PD) induced by the interaction between the number of factors viz., aging, genetics toxins, mitochondrial deformity and oxidative stress. Various evidences suggest…
  • 2017 International Congress

    In silico predictive analytics: accelerating identification of potential disease-modifying compounds for Parkinson’s disease

    N. Visanji, A. Lacoste, S. Spangler, E. Argentinis, S. Ezell, C. Marras, L. Kalia (Toronto, ON, Canada)

    Objective: To use an in silico screen to identify compounds that have potential to reduce α-synuclein (aSyn) oligomers and are amenable to drug repurposing for…
  • 2017 International Congress

    Evaluation of Swallowing Function in Parkinson’s Disease Patients with and without Dysphagia Complaints

    E. Umay, E. Ozturk, I. Gundogdu, O. Delibas, A. Cakci, B. Gonenli, Y. Eren (Ankara, Turkey)

    Objective: To assess swallowing functions of symptomatic and asymptomatic patients Parkinson's disease (PD). Background: Swallowing studies in PD without dysphagia symptoms are lacking and swallowing…
  • 2017 International Congress

    Dural lymphatic vasculature in human superior saggital sinus: the brain drain

    N. Visanji, A. Lang, D. Munoz (Toronto, ON, Canada)

    Objective: To provide independent validation in human dura obtained at autopsy of the reported presence of dural lymphatic vessels. Background: Two recent studies have challenged…
  • 2017 International Congress

    Intracortical plasticity is preserved in de novo Parkinson’s disease: a tSMS study.

    M. Dileone, V. Catanzaro, J. Obeso, G. Foffani (Mostoles, Spain)

    Objective: To test the intracortical plasticity of motor cortex in treatment-naïve (de novo) patients with Parkinson’s disease (PD), by means of transcranial static magnetic field…
  • 2017 International Congress

    Salivary Alpha-Synuclein in Aging

    G. Vivacqua, A. Fabbrini, A. Suppa, R. Mancinelli, G. Fabbrini, C. Colosimo, A. Berardelli (Rome, Italy)

    Objective: We measured alpha-synuclein total (a-syntotal) and alpha-synuclein oligomers (a-synolig) concentration in 70 healthy subjects, of different ages (from 18 to 88 years old) to…
  • 2017 International Congress

    Exposure to bifenthrin contributes to Parkinson’s disease in mouse model

    C. Han, S. Liu, J. Huang, L. Liu, K. Ma, X. Guo, S. Guo, L. Wang, Y. Shen, Y. Xia, F. Wan, N. Xiong, T. Wang (Wuhan, China)

    Objective: To explore the relationship between pyrethroid bifenthrin and Parkinson’s disease on mouse model. Background: Pyrethroid is now widely used on account of its high…
  • « Previous Page
  • 1
  • …
  • 1430
  • 1431
  • 1432
  • 1433
  • 1434
  • …
  • 1734
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • “Magic carpet for freezing of gait ” Evaluating a combination of patterned and pictographic visual cues.
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley